|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets | |||||
| Cash | |||||
| Deferred offering cost | |||||
| Prepaid expenses | |||||
| Total Current Assets | |||||
| Other long-term assets | |||||
| Marketable securities held in Trust Account | |||||
| TOTAL ASSETS | |||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||
| Current liabilities | |||||
| Accrued offering costs | |||||
| Promissory note - related party | |||||
| Accrued expenses | |||||
| Income tax payable | |||||
| Total Current Liabilities | |||||
| Deferred legal fee | |||||
| Warrant liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Class A common stock, $0.001 par value; 85,000,000 shares authorized; 25,000,000 shares subject to possible redemption at redemption value | |||||
| Class A Common Stock | |||||
| Total class A common stock, $0.001 par value; 85,000,000 shares authorized; 25,000,000 shares subject to possible redemption at redemption value | |||||
| Stockholders' Deficit | |||||
| Preferred stock, $0.001 par value; 1,000,000 shares authorized, none issued and outstanding | |||||
| Common stock | |||||
| Class A Common Stock | |||||
| Class B Common Stock | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Stockholders' Deficit | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...